Investigational antibody targets a modified form of beta amyloid called N3pG

MHRA submission is based on same application filed with the EMA

Plan aims to rapidly scale-up COVID-19 vaccination programme

Framework identifies four key priorities and five ‘underpinning themes’

CCS1477 has a novel mechanism of action compared to existing treatments

Study will evaluate the role of smart devices on monitoring cognitive health

W2O Group rolls up 2 new data agency buys into one health tech business bbulik Mon, 01/11/2021 – […]

JPM: ‘Very soon,’ says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data esagonowsky Mon, […]

Novartis lays out $650M-plus for BeiGene’s tislelizumab as its own PD-1 fails to impress aliu Tue, 01/12/2021 – […]

Novavax taps Baxter for commercial production as COVID-19 vaccine nears finish line fkansteiner Tue, 01/12/2021 – 08:51